Transitional care of GH deficiency: When to stop GH therapy

European Journal of Endocrinology

Volumn 151, Issue SUPPL. 1, 2004, Pages

  Savage, Martin O ^a,b   Drake, W M ^a   Carroll, P V ^a   Monson, J P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GROWTH HORMONE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY MASS; BONE DENSITY; BONE GROWTH; BONE MASS; BONE MINERAL; BONE TURNOVER; CHILD; CLINICAL TRIAL; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLOW UP; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; BODY COMPOSITION; BODY HEIGHT; BONE DENSITY; GROWTH DISORDERS; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM;

EID: 4644299173     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.151S061     Document Type: Article

References (29)

1. Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S & Johanson A. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. Journal of Clinical Endocrinology and Metabolism 1997 82 418-420.
2. Jørgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE & Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989 1 1221-1225.
3. Salomon F, Cuneo RC, Hesp R & Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 1989 321 1797-1803.
4. Tauber M, Moulin P, Pienkowski C, Jouret B & Rochiccioli P. Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. Journal of Clinical Endocrinology and Metabolism 1997 82 352-356.
5. Toogood AA & Shalet SM. Diagnosis of severe growth hormone (GH) deficiency in young adults who received GH replacement therapy during childhood. Acta Paediatrica Supplement 1997 423 117-120.
6. Nicolson A, Toogood AA, Rahim A & Shalet SM. The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood. Clinical Endocrinology 1996 44 311-316.
7. Shalet SM, Toogood A, Rahim A & Brennan BM. The diagnosis of growth hormone deficiency in children and adults. Endocrine Reviews 1998 19 203-223.
8. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 379-381.
9. Lange M, Svendsen OL, Skakkebaek NE, Muller J, Juul A, Schmiegelow M & Feldt-Rasmussen U. An audit of the insulin-tolerance test in 255 patients with pituitary disease. European Journal of Endocrinology 2002 147 41-47.
10. Jones SL, Trainer PJ, Perry L, Wass JA, Bessser GM & Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clinical Endocrinology 1994 41 123-128.
11. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA & Strasburger CJ. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. Journal of Clinical Endocrinology and Metabolism 1997 82 82-88.
12. Rutherford OM, Jones DA, Round JM, Buchanan CR & Preece MA. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clinical Endocrinology 1991 34 469-475.
13. Colle M & Auzerie J. Discontinuation of growth hormone therapy in growth-hormone-deficient patients: assessment of body fat mass using bioelectrical impedance. Hormone Research 1993 39 192-196.
14. de Boer H & van der Veen EA. Why retest young adults with childhood-onset growth hormone deficiency? Journal of Clinical Endocrinology and Metabolism 1997 82 2032-2036.
15. Wacharasindhu S, Cotterill AM, Camacho-Hubner C, Besser GM & Savage MO. Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth. Clinical Endocrinology 1996 45 553-556.
16. Johannsson G, Albertsson-Wikland K & Bengtsson BA. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. Journal of Clinical Endocrinology and Metabolism 1999 84 4516-4524.
17. Vahl N, Juul A, Jorgensen JO. Orskov H, Skakkebaek NE & Christiansen JS. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2000 85 1874-1881.
18. Norrelund H, Vahl N, Juul A, Moller N, Alberti KG, Skakkebaek NE, Christiansen JS & Jørgensen JO. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. Journal of Clinical Endocrinology and Metabolism 2000 85 1912-1917.
19. Carroll PV, Drake WM, Metcalfe KA, Maher KT, Savage MO, Danger DB, Shaw NJ, Cheetham TD, Camacho-Hubner C & Monson JP. Growth hormone (GH) treatment is an important regulator of insulin sensitivity in the adolescent with severe GH-deficiency. 84th Annual Endocrine Meeting of the Endocrine Society, San Francisco 2002 P3-578.
20. Randle PJ, Garland PB, Hales CN & Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963 1 785-789.
21. Bonjour JP, Theintz G, Buchs B, Slosman D & Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. Journal of Clinical Endocrinology and Metabolism 1991 73 555-563.
22. Matkovic V, Jelic T, Wardlaw GM, Ilich JZ, Goel PK, Wright JK, Andon MB, Smith KT & Heaney RP. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. Journal of Clinical Investigation 1994 93 799-808.
23. Kaufman JM, Taelman P, Vermeulen A & Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. Journal of Clinical Endocrinology and Metabolism 1992 74 118-123.
24. de Boer H, Blok GJ, van Lingen A, Teule GJ, Lips P & van der Veen EA. Consequences of childhood-onset growth hormone deficiency for adult bone mass. Journal of Bone and Mineral Research 1994 9 1319-1326.
25. Genant HK, Engelke K, Fuerst T, Gluer CC, Grampp S, Harris ST, Jergas M, Lang T, Lu Y, Majumdar S, Mathur A & Takada M. Non-invasive assessment of bone mineral and structure: state of the art. Journal of Bone and Mineral Research 1996 11 707-730.
26. Saggese G, Baroncelli GI, Bertelloni S & Barsanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. Journal of Clinical Endocrinology and Metabolism 1996 81 3077-3083.
27. Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hubner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO & Monson JP. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. Journal of Clinical Endocrinology and Metabolism 2003 88 1658-1663.
28. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial, The Writing Group for the PEPI. Journal of the American Medical Association 1996 276 1389-1396.
29. Attanasio AF, Howell S, Bates PC, Chipman J, Blum WF & Shalet SM. Body composition, IGF-I, IGFBP-3 concentrations as outcome measures in severely GH deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. Journal of Clinical Endocrinology and Metabolism 2002 87 3368-3370.